This document discusses GERD (gastroesophageal reflux disease). It provides an overview of GERD including a classification system, symptoms, diagnostic tests like pH monitoring, and subtypes such as erosive esophagitis. Alarm symptoms that may indicate complications are noted. Causes, pathophysiology, and treatment options for various subtypes are reviewed including proton pump inhibitors, prokinetic drugs, treatments for refractory GERD, and the relationship between H. pylori infection and GERD. Newer formulations and potential future treatments are also mentioned.
Gastroesophageal Reflux Disease and Antireflux SurgeryHassan s1
this presentation describes the pathophysiology and presentation of gastroesophageal reflux disease. it also discusses the medical and surgical management of gastroesophageal reflux disease.. what makes this presentation unique is that it explains the short and long term effects of antireflux surgery and patient's satisfaction with this surgery with references.
GERD (Gastro Esophageal Reflux Disease) is one of the commonest medical conditions found in the community today. GERD patients often suffer from frequent symptoms and require long term medication. However, how much of what we know about GERD is truly fact based on medical evidence? We challenge traditional paradigms to GERD
GERD is a day to day common problem, which is on the increase due to so many obvious reasons. It needs to be addressed to the public and the medical fraternity for proper management and treatment.
GERD ( Gasrtro-esophageal reflux disease )
Gastroesophageal reflux disease (GERD) is a condition in which the stomach contents (food or liquid) leak backwards from the stomach into the esophagus (the tube from the mouth to the stomach). This action can irritate the esophagus, causing heartburn and other symptoms.
And Case study at the end
Gastroesophageal Reflux Disease and Antireflux SurgeryHassan s1
this presentation describes the pathophysiology and presentation of gastroesophageal reflux disease. it also discusses the medical and surgical management of gastroesophageal reflux disease.. what makes this presentation unique is that it explains the short and long term effects of antireflux surgery and patient's satisfaction with this surgery with references.
GERD (Gastro Esophageal Reflux Disease) is one of the commonest medical conditions found in the community today. GERD patients often suffer from frequent symptoms and require long term medication. However, how much of what we know about GERD is truly fact based on medical evidence? We challenge traditional paradigms to GERD
GERD is a day to day common problem, which is on the increase due to so many obvious reasons. It needs to be addressed to the public and the medical fraternity for proper management and treatment.
GERD ( Gasrtro-esophageal reflux disease )
Gastroesophageal reflux disease (GERD) is a condition in which the stomach contents (food or liquid) leak backwards from the stomach into the esophagus (the tube from the mouth to the stomach). This action can irritate the esophagus, causing heartburn and other symptoms.
And Case study at the end
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
14. The “Richter Scale/Acid Test” to see if
you’re a GERD sufferer or not
1- Do you frequently have one or more of the following:
• a. an uncomfortable feeling behind the breastbone that
seems to be moving upward from the stomach?
• b. a burning sensation in the back of your throat?
• c. a bitter acid taste in your mouth?
2- Do you often experience these problems after meals?
3- Do you experience heartburn or acid indigestion two or more
times per week?
4- Do you find that antacids only provide temporary relief from
your symptoms?
5- Are you taking prescription medication to treat heartburn,
but still having symptoms?
If you
said
yes
to two
or
more
of the
above,American College of Gastroenterology - March 16, 2010
Digestive Disease Specialists Committed to
Quality in Patient Care
15.
16.
17. 1- Dysphagia/odynophagia ( مؤلم )بلع
2- Nausea/vomiting
3- Melena, anemia.
4- Weight loss, anorexia
5- Extended duration of symptoms
6- No response to PPI
7- Family history of PUD
8- Caucasian Male, 50+ years old .
Patients with these symptoms are more likely to
have peptic strictures or esophagitis.
Barrett’s esophagus is three to six times more likely
in patients who have had symptoms of GERD for
Alarming Symptoms ( Red Flags):
suggestive of complicated disease include:
19. Heartburn and normal endoscopy
Functional heartburn - normal /
physiological range of acid exposure
Abnormal acid exposure
Negative
relationship
between symptoms
and acid reflux
events (S1 < 50 %)
Hypersensitive
oesophagus-
positive
relationship
between
symptoms and
acid reflux events
(S1≥ 50%)
Fass, R et al. Gut 2002;51:885-892
Non acid related
stimuli (motor
event, non acid
reflux)
Minute changes
in intra-
oesophagea pH
(pH ≥4)
30% - 50%50% - 70%
60%40%
NERD
20. Clinical features of functional
heartburn
Absence of regurgitation
Common overlap syndromes particularly with FD
and IBS
Common association with psychological
stress.
Poor response to PPI
21. • A number of mechanisms have been
suggested:--
1- Increased esophageal sensitivity to acid,
2- Non-acid reflux episodes,
3- Increased esophageal mechanosensitivity ,
4- Esophageal motor disorders, or
5- Psychological abnormalities.
Pathophesiology of
Functional heartburn
22. Patient Related factors Therapy related factors
Compliance
Motility Disorder
Eosinophilic Esophagitis
Hypersensitive Esophagus
Non-Acidic Reflux
Psychological Comorbidity
Eradication of Helicobacter
Pylori infection
Nocturnal Acid Breakthrough
(NAB)
Resistance to PPIs
Rapid Metabolism of PPIs
Causes of Refractory GERD
23. When to suspect?
Long standing esophageal symptoms
such as dysphagia with or without
food impaction.
Refractory heartburn on PPIs
Allergic history
Peripheral Eosinophilia
Elevated IgE
Eosinophilic Esophagitis
24. Use of Eosinophilic Density to
Guide Therapy?
No. of eosinophils per HPF
<5 5-20 >20
Consider
aggressive
antireflux Rx
?
Consider Rx for
allergy or primary
eosinophilic
esophagitis
• Identify and eliminate food allergen
• Steroids — systemic, topical
31. Helicobacter pylori and GERD
- Eradication of H. pylori is associated
with mild worsening of GERD in patients
with corpus-predominant gastritis and
improvement in those with antral-
predominant gastritis.
- The standard of care is to eradicate H.
pylori in the context of peptic ulcer
disease.
32. The interaction between GERD and H pylori is complicated
and depends on the type of infection.
- Antral-predominant H pylori infection, which is the most common
type in the United States, is associated with increased acid and
duodenal ulcers and a 2- to 3-fold increased risk of adenocarcinoma.
This type of H pylori can worsen reflux; treating it may improve reflux
symptoms.
- In contrast, studies from Asia where body-predominant H pylori
infection is prevalent show that it protects against Barrett’s
esophagus and adenocarcinoma. Currently, there are no data to
support testing for H pylori in the management of GERD as
eradication should not dramatically alter GERD severity in patients
undergoing treatment.
33.
34. The question of debate and controverse:
Inspite of GERD is a motility disorder and
Gastric acid secretion is normal & pH is > 4
in most of patients with GERD.
The mainstay of treatment is PPIs
(esomepazole ) that mainly inhibit gastric acidity
(HCL) and causticity of gastric juice and not the
prokinetics.
35.
36.
37. Use of H2 blocker in era of PPI
- ON demand therapy.
- NAB.
- REFRACTORY GERD.
- MORE SAFE IN ELDERLY AND
PREGNANCY???.
- IF YOU NEED PROKINETIC : ?NIZATIDINE.
38. Martinez et al., Aliment Pharmacol Ther,.2003
Treatment of Functional Heartburn
Hypersensitive esophagus
Acid sensitive
Non acid related
Minute changes in
intraesophageal (PH> 4)
Non-acid related stimuli
( Motor event)
High dose PPIs
GABA receptor antagonists
High dose PPIs
Tegaserod
Pain modulators
41. The proton pump inhibitors
( PPIs )
•1- Omeprazole 2- Lansoprazole. 3- Pantoprazole. 4-
Rabeprazole. 5- Esomeprazole.
• PPIs are also prodrugs that are highly
selective to the acidic environment
within the secretory canaliculi of the
gastric parietal cells
substituted
benzimidazoles
• 1- Tenatoprazole.
• 2- Benatoprazole (TU 199)
• - Prolonged plasma half life (7 h.)
• 2-4 fold more potent than omeprazole
Imidazopyridine
derivative
( New PPIs )
• 1- Immediate-release omeprazole
(IR-OME) prowder for oral
suspension
• 2- Immediate-release omeprazole in
a capsule formulation
New
Pharmaceutical
Preparation
42. Important to remember ...
ALL PPIs drugs
Are
Pro Drugs - Weak bases
The absorption takes
place
In
The Upper part of
small Intestine
46. Patient with hepatic impairement
show a seven fold increase in AUC
for PPIs and aprolonged half life.
Esomeprazole was well tolerated
across the spectrum of hepatic
impairement unlike other PPIs.
47.
48. Katz et al, Am J Med 2000; 108(suppl 4a): 170S-177S.
Symptom Medication and dose Duration
Chest pain PPI b.i.d. 1-8 weeks
Asthma PPI b.i.d. ≤3 month
Cough PPI b.i.d. 1-3 months
Upper airway PPI b.i.d. 1-3 months
Suggested Regimens for
Extra-esophageal Manifestations of GERD
49. With Esomeprazole , more compound is available to inhibit gastric
proton pumps compared with omeprazole
LiverLiver
Esomeprazole
Absorption
Enhanced
delivery to the
proton pump
Metabolites
Advantageous first-pass metabolism decreased
MetabolitesFirst-pass
metabolism
Absorption
Omeprazole
50.
51. Prokinetic (Promotility ) drugs
drugs that enhance the emptying of the stomach and/or gut and enhance the contractions/co-
ordination of the gut. Here is a list of the more common prokinetics in use for treating
gastroparesis and related dysmotilities
• Cisapride (still available under compassionate-release programs)
• Domperidone (Motilium®)
• Metoclopromide .
• Levosulpiride (Levobren®, Levopraid®, available in Italy/Korea)
• Erythromycin (low dosages, not antibiotic dosing levels)
• Tegaserod ( Zelmac®, now only available under special FDA protocols)
• Mosapride Citrate ( available in Asia, SE Asia, South America, and Japan)
• Itopride hydrochloride (Ganaton®, available in Asia, SE Asia, and Japan)
• Renzapride (2008, a Phase III trial in USA has been completed)
• Pruclopride (Resolor®, available in the UK and EU countries)
52. is a prokinetic benzamide derivative unlike
metoclopramide or domperidone. These
drugs inhibit dopamine and have a
gastrokinetic effect.
Itopride is indicated for the treatment of
functional dyspepsia and other gastrointestinal
conditions.
It is a combined D2 receptor antagonist and
acetylcholinesterase inhibitor.
Itopride
(brand name Ganaton)
53. Mosapride
• is a gastroprokinetic agent that acts as a selective 5HT4 agonist. The
major active metabolite of mosapride, known as M1, additionally acts
as a 5HT3 antagonist.which accelerates gastric emptying throughout
the whole of the gastrointestinal tract in humans, and is used for the
treatment of gastritis, gastroesophageal reflux disease, functional
dyspepsia and irritable bowel syndrome. It is recommended to be
taken on an empty stomach (i.e. at least one hour before food or two
hours after food).
• In addition to its prokinetic properties, mosapride also exerts anti-
inflammatory effects on the gastrointestinal tract which may
contribute to some of its therapeutic effects. Mosapride also
promotes neurogenesis in the gastrointestinal tract which may prove
useful in certain bowel disorders. The neurogenesis is due to
mosapride's effect on the 5-HT4 receptor where it acts as an agonist